期刊文献+

组蛋白去乙酰化酶抑制剂Trichostatin—A诱导人乳腺癌MCF-7细胞凋亡的机制 被引量:2

Mechanisms of TSA-Induced apoptosis of MCF-7 breast cancer cells
原文传递
导出
摘要 目的探讨组蛋白去乙酰化酶抑制剂Trichostatin-A(TSA)诱导肿瘤细胞凋亡的机制。方法显微镜下观察TSA作用24、48h后,小鼠NIH3T3成纤维细胞、人乳腺癌MCF-7细胞的形态学变化,采用流式细胞学方法(FCM)检测细胞凋亡情况。利用Western blot方法检测细胞周期相关蛋白Rb蛋白和凋亡相关蛋白多聚ADP核糖聚合酶(PARP)降解片段的表达。结果TSA作用后的NIH3T3细胞,生长变得缓慢,但细胞尚保持生长的活性。MCF-7细胞24、48h的凋亡率分别为(36.4±1.5)%、(67.0±2.8)%,以48h最明显。TSA作用24、48、72h后,两种细胞均出现不同程度的磷酸化Rb蛋白水平下降,MCF-7细胞中PARP发生明显的降解,48h后降解明显,72h达到最大程度。结论TSA可诱导MCF-7细胞凋亡,其机制可能通过改变肿瘤细胞核染色质的空间结构,以及阻滞细胞周期实现的。 Objective To investigate the mechanisms of apoptosis by the drug Trichostatin-A (TSA) treatment in MCF-7 breast cancer ceil line, Methods The morphological change of ceils was ob- served by microscope after NIH 3T3 ,MCF-7 cells treated with TSA for 24,48 h. Flow eytometry was used to detect the apoptosis of the ceils. The expression of poly ADP-ribose polymerase PARP was detected by Western blot. Results The growth of the NIH 3T3 ceils become very slow after treatment with TSA, but these cells still survived. Meanwhile ,the apoptotic rate of MCF-7 cells was (36.4 ± 1.5) % and ( 67.0 ± 2.8) % after treatment with TSA for 24 and 48 h, more obviously for 48 h ( P 〈 0.01 ). The expression of phosphorylated Rb protein was decreased in the NIH3T3 and MCF-7 cells. Simultaneously, PARP degradation was observed in MCF-7 cells,more obvious at 48 h,and reached the peak at 72 h. Conclusion TSA can induce the apoptosis of tumor cell MCF-7 ,which may be related to the change in chromatin conformation and blockade of cell cycle.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2008年第4期450-451,共2页 Chinese Journal of Experimental Surgery
基金 上海市浦东新区优秀青年医学人才培养计划资助项目(PWRq2007-05) 同济大学医科基金资助项目(TJ05-1)
关键词 乳腺肿瘤 脱噬作用 组蛋白 去乙酰化酶 Breast neoplasms Apoptosis Histone Deacetylase
  • 相关文献

参考文献6

  • 1Gabrilli BG,Johnstone RW,Saunders NA.dentifying molecular targets mediating the anticancer activity of histone doacetylase inhibitors:a work in progress Curr Cancer Drug Targets,2002,2:337-353.
  • 2Marks PA,Richon VM,Breslgw R,et al.Histone deacetylase inhibitors as new cancer drugs,Curr Opln Oncol,2001,13:477-483.
  • 3Knsugi H,Towatari M,Hatano S,et al.Histone deacetylase inhibitors are the potent omfivrt/enhancer of differentiation in acute myeloid leukemia:a new approach to anti-leukemia therapy.Leukemia,1999,13:1316-1324.
  • 4王波涌,邵荣江,雷道雄,艾中立.丁酸钠诱导人肝癌细胞凋亡机制[J].中华实验外科杂志,2006,23(11):1412-1412. 被引量:4
  • 5Hirsch CL,Smith-Windsor El,Bonham K,Sro family kinase members have a common response to histone deacetylase inhibitors in human colon cancer cells.Int J Cancer,2006,118:547-554.
  • 6杨维良,张东伟.乳腺癌基因治疗的研究现状及展望[J].中华实验外科杂志,2005,22(5):633-635. 被引量:15

二级参考文献19

  • 1Naidu R,Wahab NA,Yadav M,et al.Protection expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.Int J Mol Med,2002,9:189-196.
  • 2Ciesielski D,Dziewulska BA,Ioltowska A,et al.p53 expression in breast cancer related to prognostic factors.Neoplasma,1995,42:235-237.
  • 3Arteaga CL,Holt JT.Tissue-targeted antisense c-fos retroviral vector inhibits established breast cancer xenografts in nude mice.Cancer Rea,1996,56:1098-1103.
  • 4Lee EJ,Jakacka M,Duan WR,et al.Adenovirus-directed expression of dominant negative estrogen receptor induces apoptosis in breast cancer cells and regression of tumors in nude mice.Mol Med,2001,7:773-782.
  • 5Obermiller PS,Tait DL,Holt JT.Gene therapy for carcinoma of the breast::Therapeutic genetic corretion strategies.Breast Cancer Res,2000,2:28-31.
  • 6Xu HJ,Zhou Y,Seigne J,et al.Enhanced tumor suppressor gene therapy via replication-deficient adenovirus vectors expressing an N-terminal truncated retinoblastoma protein.Cancer Res,1996,56:2245-2249.
  • 7Li Z,Shanmugan N,Katayose D,et al.Enzyme/prudrug gene therapy approach for breast cancer using a recombinant adenovirus expressing escherichia coli cytosine deaminase.Cancer Gene Ther,1997,4:113-117.
  • 8Pandha HS,Martin LA,Rigg A,et al.Genetic prodrug activation therapy for breast cancer:A phase clinical trial of erbB-2-directed suicide gene expression.J Clin Oncol,1999,17:2180-2189.
  • 9Teshigahara O,Goshima F,Takao K,et al.Oncolytic viral therapy for breast cancer with herpes simplex virus type 1 mutant HF 10.J Surg Oncol.,2004,85:42-47.
  • 10Shi FS,Weber S,Gan J,et al.Granulocyte-macrophage-colony-stimulating factor (GM-CSF) secreted by cDNA transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF.Cancer Gene Ther,1999,6:81-88.

共引文献17

同被引文献24

  • 1任宝波,王玉艳,王纯净,李士泽,杨焕民.HSP70家族的分类及基因结构与功能[J].动物医学进展,2005,26(1):98-101. 被引量:38
  • 2朱熊兆,亓晓丽,姚树桥,彭敏.热休克蛋白70对小鼠海马CA3区神经元损伤的保护作用[J].中国心理卫生杂志,2006,20(7):425-429. 被引量:8
  • 3陈峻严,黄金钟,黄种心,邱建龙,周培萱.颅脑外伤后局部脑组织HSP70基因的表达[J].中华创伤杂志,2006,22(8):623-624. 被引量:8
  • 4龚英,汪登斌.两种MDA-MB-231乳腺癌细胞原位移植型裸鼠模型制作比较[J].上海交通大学学报(医学版),2007,27(7):818-821. 被引量:7
  • 5Kang HB, Zhang YF, Yang JD, et al. Study on soy isoflavone con- sumption and risk of breast cancer and survival[ J]. Asian Pac J Canc- er Prey,2012,13(3) :995-998.
  • 6Starvold GL, Andersen TI,Pemu CM, et al. siRNA :a potential tool for future breast cancer therapy [ J ]. Crit Rev Oncog, 2006, 12 ( 1-2 ) : 127-150.
  • 7Gao JL,Ji X,He TC ,et al. Tetrandrine Suppresses Cancer Angiogene- sis and Metastasis in 4TI Tumor Bearing Mice[J]. Evid Based Com- plement Altemat Med ,2013,13 (5) :261-266.
  • 8Lebeau A. Precancerous Lesions of the Breast [ J ]. Breast Care ( Ba- sel) ,2010,5(4):204-206.
  • 9Zhang L, Bi L, Shi J, et al. A quantitative diagnostic method for oral mucous precancerosis by Rose Bengal fluorescence spectroscopy [ J]. Lasers Med Sci ,2013,28( 1 ) :241-246.
  • 10Baskaran N, Manoharan S, Balakrishnan S, et al. Chemopreventive po- tential of ferulic acid in 7,12-dimethylbenz [ a] anthracene-induced mammary carcinogenesis in Sprague-Dawley rats [ J ]. Eur J Pharma- col,2010,637( 1-3 ) :22-29.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部